FindMyKOL

John Dumot, DO

Basic profile

University Hospitals of Cleveland

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionCleveland, OH · MidwestSpecialtyGastroenterologyFocusGastroenterology
Active KOLFindMyKOL type: NationalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Dumot is a Gastroenterology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 267 publications with 7,039 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
267publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

7,039citations

Citations across these publications.

47h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • US ENDOSCOPY
    Program year20252 payments
    $4,000
  • Phathom Pharmaceuticals, Inc.
    Program year20251 payment
    $122
  • Aimmune Therapeutics, Inc.
    Program year20254 payments
    $85
All 25 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    77.4%
    Proton pump inhibitor35.2%
    Omeprazole43%Pantoprazole Sodium35%Esomeprazole Magnesium13%Lansoprazole8%
    Part D<11 patients
    Antidiarrheal microorganisms8.6%
    Creon100%
    Part D≥26 patients

    + 13 more classes in this area

  • Cardiovascular

    10.5%
    Bile Acid Sequestrant5.2%
    Colestipol Hcl58%Cholestyramine42%
    Part D≥13 patients
    Beta blocker1.6%
    Carvedilol100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    10.3%
    Tricyclic Antidepressant5%
    Amitriptyline Hcl100%
    Part D≥20 patients
    Gabapentinoids1.9%
    Gabapentin100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)64.3% facility · 35.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”